Literature DB >> 8732916

Asbestos exposure and ovarian fiber burden.

D S Heller1, R E Gordon, C Westhoff, S Gerber.   

Abstract

Epidemiologic studies suggest increased risk of epithelial ovarian cancer in female asbestos workers and increased risk of malignancy in general in household contacts of asbestos workers. Ovaries were studied from 13 women with household contact with men with documented asbestos exposure and from 17 women undergoing incidental oophorectomy. Ovarian tissue was examined by analytic electron microscopy. Significant asbestos fiber burdens were detected in 9 out of 13 women with household asbestos exposure (69.2%), and in 6 out of 17 women who gave no exposure history (35%). Three exposed women had asbestos counts over 1 million fibers per gram wet weight (23%), but only 1/17 women without an exposure history had a count that high (6%). Although asbestos has been documented as a contaminant of some older cosmetic talc preparations, the chrysotile and crocidolite types of asbestos we detected are more indicative of background and/or occupational exposure. This study demonstrates that asbestos can reach the ovary. Although the number of subjects is small, asbestos appears to be present in ovarian tissue more frequently and in higher amounts in women with a documentable exposure history.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732916     DOI: 10.1002/(SICI)1097-0274(199605)29:5<435::AID-AJIM1>3.0.CO;2-L

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  16 in total

1.  Response to RE: Gordon R, Fitzgerald S, and Millette J. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 2014;20(4):318-332.

Authors:  Ronald E Gordon
Journal:  Int J Occup Environ Health       Date:  2015

2.  Response to Gordon 2016.

Authors:  Richard Lee; Drew Van Orden; Matt Sanchez
Journal:  Int J Occup Environ Health       Date:  2016-10-13

3.  Response to Second Letter by Lee et al. of 2016.

Authors:  Ronald E Gordon
Journal:  Int J Occup Environ Health       Date:  2017-11-17

4.  Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women.

Authors:  Ronald E Gordon; Sean Fitzgerald; James Millette
Journal:  Int J Occup Environ Health       Date:  2014-09-03

5.  Geographic Co-Occurrence of Mesothelioma and Ovarian Cancer Incidence.

Authors:  S Jane Henley; Lucy A Peipins; Sun Hee Rim; Theodore C Larson; Jacqueline W Miller
Journal:  J Womens Health (Larchmt)       Date:  2019-07-16       Impact factor: 2.681

6.  Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).

Authors:  Joellen M Schildkraut; Sarah E Abbott; Anthony J Alberg; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Lauren C Peres; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Fabian Camacho; Frances Wang; Patricia G Moorman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-12       Impact factor: 4.254

Review 7.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

8.  Malignant tumors of the female reproductive system.

Authors:  Elisabete Weiderpass; France Labrèche
Journal:  Saf Health Work       Date:  2012-08-30

9.  Occupational exposure to asbestos and ovarian cancer: a meta-analysis.

Authors:  M Constanza Camargo; Leslie T Stayner; Kurt Straif; Margarita Reina; Umaima Al-Alem; Paul A Demers; Philip J Landrigan
Journal:  Environ Health Perspect       Date:  2011-06-03       Impact factor: 9.031

10.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.